These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 24615308)
1. Barriers to primary care physicians prescribing buprenorphine. Hutchinson E; Catlin M; Andrilla CH; Baldwin LM; Rosenblatt RA Ann Fam Med; 2014; 12(2):128-33. PubMed ID: 24615308 [TBL] [Abstract][Full Text] [Related]
2. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder. Jones CM; McCance-Katz EF Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876 [TBL] [Abstract][Full Text] [Related]
3. Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters. Quest TL; Merrill JO; Roll J; Saxon AJ; Rosenblatt RA J Opioid Manag; 2012; 8(1):29-38. PubMed ID: 22479882 [TBL] [Abstract][Full Text] [Related]
4. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians. Andrilla CHA; Moore TE; Patterson DG J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720 [TBL] [Abstract][Full Text] [Related]
5. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program. Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802 [TBL] [Abstract][Full Text] [Related]
6. Practice Predictors of Buprenorphine Prescribing by Family Physicians. Peterson LE; Morgan ZJ; Borders TF J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252 [TBL] [Abstract][Full Text] [Related]
7. Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians. Rowan K; Shah SV; Binns S; Murphy E; Satorius J; Ghobadi A; Krauss D; Robbins C; Schoebel V; Knudson A; Kepley H; JAMA Netw Open; 2024 May; 7(5):e2411742. PubMed ID: 38758556 [TBL] [Abstract][Full Text] [Related]
8. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder. Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272 [TBL] [Abstract][Full Text] [Related]
9. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine. Andrilla CHA; Jones KC; Patterson DG J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634 [TBL] [Abstract][Full Text] [Related]
10. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder. Andrilla CHA; Coulthard C; Larson EH Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273 [TBL] [Abstract][Full Text] [Related]
11. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. Walley AY; Alperen JK; Cheng DM; Botticelli M; Castro-Donlan C; Samet JH; Alford DP J Gen Intern Med; 2008 Sep; 23(9):1393-8. PubMed ID: 18592319 [TBL] [Abstract][Full Text] [Related]
12. Buprenorphine prescribing practice trends and attitudes among New York providers. Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694 [TBL] [Abstract][Full Text] [Related]
13. Buprenorphine Waiver Attitudes Among Primary Care Providers. Lai B; Croghan I; Ebbert JO J Prim Care Community Health; 2022; 13():21501319221112272. PubMed ID: 35822763 [TBL] [Abstract][Full Text] [Related]
14. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Rosenblatt RA; Andrilla CH; Catlin M; Larson EH Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888 [TBL] [Abstract][Full Text] [Related]
15. Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder. Jones J; Tierney M; Jacobs G; Chien SY; Mallisham S J Addict Nurs; 2020; 31(4):261-268. PubMed ID: 33264198 [TBL] [Abstract][Full Text] [Related]
17. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements. Christine PJ; Chahine RA; Kimmel SD; Mack N; Douglas C; Stopka TJ; Calver K; Fanucchi LC; Slavova S; Lofwall M; Feaster DJ; Lyons M; Ezell J; Larochelle MR JAMA Netw Open; 2024 Aug; 7(8):e2425999. PubMed ID: 39102264 [TBL] [Abstract][Full Text] [Related]
18. Initiation of Buprenorphine in the Emergency Department: A Survey of Emergency Clinicians. Barkley A; Lander L; Dilcher B; Tuscano M West J Emerg Med; 2024 Jul; 25(4):470-476. PubMed ID: 39028232 [TBL] [Abstract][Full Text] [Related]
19. Preliminary results of the evaluation of the California Hub and Spoke Program. Darfler K; Sandoval J; Pearce Antonini V; Urada D J Subst Abuse Treat; 2020 Jan; 108():26-32. PubMed ID: 31400985 [TBL] [Abstract][Full Text] [Related]
20. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine. Peterson LE; Morgan ZJ; Eden AR J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]